Clinical Trials Directory

Trials / Sponsors / Ortho Biotech Products, L.P.

Ortho Biotech Products, L.P.

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
CompletedDosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia
Anemia, Cancer
—2003-12-01
TerminatedA Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa)
Anemia, Kidney Diseases
Phase 42003-11-01
TerminatedA Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.
Anemia, Chronic Renal Insufficiency
Phase 42003-06-01
CompletedHematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemi
Anemia, Chemotherapy
Phase 42003-02-01
TerminatedA Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy
Anemia, Breast Neoplasms, Hemoglobins
Phase 32002-12-01
TerminatedRAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining He
Chemotherapy, Cancer, Anemia
Phase 42002-11-01
CompletedAn Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 U
Anemia, HIV Infections
Phase 42002-10-01
TerminatedA Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to C
Anemia, Neoplasms
Phase 32002-09-01
CompletedA Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chro
Anemia, Chronic Renal Insufficiency
Phase 22002-01-01
CompletedA Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Riba
Hepatitis C, Anemia
Phase 22001-10-01
CompletedNATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection
Hepatitis C, HIV, Anemia
Phase 22000-09-01
CompletedA Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Ch
Anemia, Hodgkin Disease, Leukemia
Phase 32000-08-01
WithdrawnOpen-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arth
Anemia, Rheumatoid Arthritis
Phase 2—